Perspectives: artificial intelligence and dermatological peptide design Generative AI tools (AlphaFold 3, RFdiffusion, ESM-3) are transforming the design of new dermatological peptides: De novo design of peptides binding to specific cutaneous receptors (EGFR, FGFR, MC1R) Cutaneous penetration prediction by QSAR/ML models integrating physicochemical properties Multiparametric optimisation : stability, solubility, activity, non-toxicity treated simultaneously Virtual peptide libraries computationally screened before real SPPS synthesis For an academic laboratory, these approaches reduce the number of peptides to physically synthesise by several orders of magnitude
Product: Molecular structure: Key differences Understanding the molecular structures of SLU-PP-332 and 5-amino-1mq is crucial for grasping their potential therapeutic effects and mechanisms of action
Treatment upregulated protein translation components and stimulated the transsulfuration pathway for oxidative stress protection, with no reported adverse events (Dimet-Wiley et al., 2024)
Anytime theres drastic awareness, it changes things.
